1. Home
  2. BBIO vs BWBBP Comparison

BBIO vs BWBBP Comparison

Compare BBIO & BWBBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • BWBBP
  • Stock Information
  • Founded
  • BBIO 2015
  • BWBBP N/A
  • Country
  • BBIO United States
  • BWBBP United States
  • Employees
  • BBIO N/A
  • BWBBP 290
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • BWBBP Major Banks
  • Sector
  • BBIO Health Care
  • BWBBP Finance
  • Exchange
  • BBIO Nasdaq
  • BWBBP Nasdaq
  • Market Cap
  • BBIO 6.7B
  • BWBBP N/A
  • IPO Year
  • BBIO 2019
  • BWBBP N/A
  • Fundamental
  • Price
  • BBIO $34.17
  • BWBBP $19.00
  • Analyst Decision
  • BBIO Strong Buy
  • BWBBP
  • Analyst Count
  • BBIO 12
  • BWBBP 0
  • Target Price
  • BBIO $57.09
  • BWBBP N/A
  • AVG Volume (30 Days)
  • BBIO 3.1M
  • BWBBP N/A
  • Earning Date
  • BBIO 04-29-2025
  • BWBBP N/A
  • Dividend Yield
  • BBIO N/A
  • BWBBP N/A
  • EPS Growth
  • BBIO N/A
  • BWBBP N/A
  • EPS
  • BBIO N/A
  • BWBBP N/A
  • Revenue
  • BBIO $127,415,000.00
  • BWBBP N/A
  • Revenue This Year
  • BBIO $13.67
  • BWBBP N/A
  • Revenue Next Year
  • BBIO $118.02
  • BWBBP N/A
  • P/E Ratio
  • BBIO N/A
  • BWBBP N/A
  • Revenue Growth
  • BBIO N/A
  • BWBBP N/A
  • 52 Week Low
  • BBIO $21.62
  • BWBBP N/A
  • 52 Week High
  • BBIO $39.47
  • BWBBP N/A
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 44.19
  • BWBBP 56.47
  • Support Level
  • BBIO $33.92
  • BWBBP $18.85
  • Resistance Level
  • BBIO $39.16
  • BWBBP $18.97
  • Average True Range (ATR)
  • BBIO 1.50
  • BWBBP 0.10
  • MACD
  • BBIO -0.24
  • BWBBP 0.05
  • Stochastic Oscillator
  • BBIO 10.35
  • BWBBP 66.86

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About BWBBP Bridgewater Bancshares Inc. Depositary Shares Each Representing a 1/100th Interest in a Share of 5.875% Non-Cumulative Perpetual Preferred Stock Series A

Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.

Share on Social Networks: